ロード中...
Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
KRAS is the most commonly mutated oncogene in human cancer. Most KRAS-mutant cancers depend on sustained expression and signaling of KRAS, thus making it a high-priority therapeutic target. Unfortunately, development of direct small molecule inhibitors of KRAS function has been challenging. An alter...
保存先:
| 出版年: | Cold Spring Harb Perspect Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cold Spring Harbor Laboratory Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990478/ https://ncbi.nlm.nih.gov/pubmed/29101114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a031518 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|